Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2017 1
2019 2
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal Emax regressions.
Beumer JH, Kennard BC, Holleran JL, Moore N, Zlott J, Miller BM, Kummar S, Chen A, Doroshow J, Park W, Gobburu J, Dunn A. Beumer JH, et al. Cancer Chemother Pharmacol. 2023 Mar;91(3):219-230. doi: 10.1007/s00280-023-04509-8. Epub 2023 Feb 23. Cancer Chemother Pharmacol. 2023. PMID: 36813886 Free PMC article.
COVID-19, Social Justice, and Clinical Cancer Research.
Doroshow JH, Prindiville S, McCaskill-Stevens W, Mooney M, Loehrer PJ. Doroshow JH, et al. J Natl Cancer Inst. 2021 Oct 1;113(10):1281-1284. doi: 10.1093/jnci/djaa162. J Natl Cancer Inst. 2021. PMID: 33057660 Free PMC article.
Genomics and the History of Precision Oncology.
Doroshow DB, Doroshow JH. Doroshow DB, et al. Surg Oncol Clin N Am. 2020 Jan;29(1):35-49. doi: 10.1016/j.soc.2019.08.003. Epub 2019 Oct 29. Surg Oncol Clin N Am. 2020. PMID: 31757312 Free PMC article. Review.
On the Design of Combination Cancer Therapy.
Doroshow JH, Simon RM. Doroshow JH, et al. Cell. 2017 Dec 14;171(7):1476-1478. doi: 10.1016/j.cell.2017.11.035. Cell. 2017. PMID: 29245008 Free PMC article.
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors.
Do K, Speranza G, Chang LC, Polley EC, Bishop R, Zhu W, Trepel JB, Lee S, Lee MJ, Kinders RJ, Phillips L, Collins J, Lyons J, Jeong W, Antony R, Chen AP, Neckers L, Doroshow JH, Kummar S. Do K, et al. Invest New Drugs. 2015 Aug;33(4):921-30. doi: 10.1007/s10637-015-0255-1. Epub 2015 Jun 18. Invest New Drugs. 2015. PMID: 26082332 Free PMC article. Clinical Trial.